Acrivon Therapeutics, Inc. Common Stock
General ticker "ACRV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $152.7M (TTM average)
Acrivon Therapeutics, Inc. Common Stock follows the US Stock Market performance with the rate: 37.5%.
Estimated limits based on current volatility of 6.0%: low 1.39$, high 1.57$
Factors to consider:
- Total employees count: 41 as of 2022
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.47$, 4.90$]
- 2026-12-31 to 2027-12-31 estimated range: [1.32$, 4.33$]
Short-term ACRV quotes
Long-term ACRV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $67.24MM | $89.20MM | $84.11MM |
| Operating Income | $-67.24MM | $-89.20MM | $-84.11MM |
| Non-Operating Income | $6.85MM | $8.64MM | $6.21MM |
| R&D Expense | $45.49MM | $63.99MM | $59.99MM |
| Income(Loss) | $-60.39MM | $-80.56MM | $-77.91MM |
| Profit(Loss)* | $-60.39MM | $-80.56MM | $-77.91MM |
| Stockholders Equity | $121.19MM | $176.79MM | $112.52MM |
| Assets | $138.26MM | $196.59MM | $129.72MM |
| Operating Cash Flow | $-42.64MM | $-65.67MM | $-63.66MM |
| Capital expenditure | $1.29MM | $2.77MM | $1.67MM |
| Investing Cash Flow | $50.72MM | $-51.77MM | $66.10MM |
| Financing Cash Flow | $-1.55MM | $121.03MM | $-0.75MM |
| Earnings Per Share** | $-2.74 | $-2.10 | $-2.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.